ResearcherUniversity of MiamiNo recent work listed
Brent A. Willobee
Matched on OpenAlex author ID A5013062358. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 1 paper · 2021: 2 papers
Papers 3
- Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review. First author DOI 10.1001/jamasurg.2020.5676↗
- Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-19-1043↗
- Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-19-0741↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nipun B. Merchant · 3 shared papers, 2020–2021 · strength 0.38
- Paper Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal … DOI 10.1001/jamasurg.2020.5676↗
- Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
- Paper Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic C… DOI 10.1158/1541-7786.mcr-19-0741↗
- Austin R. Dosch · 2 shared papers, 2020–2021 · strength 0.23
- Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
- Paper Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic C… DOI 10.1158/1541-7786.mcr-19-0741↗
- Siddharth Mehra · 2 shared papers, 2020–2021 · strength 0.23
- Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
- Paper Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic C… DOI 10.1158/1541-7786.mcr-19-0741↗
- Supriya Srinivasan · 2 shared papers, 2020–2021 · strength 0.23
- Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
- Paper Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic C… DOI 10.1158/1541-7786.mcr-19-0741↗
- Nagaraj S. Nagathihalli · 2 shared papers, 2020–2021 · strength 0.23
- Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
- Paper Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic C… DOI 10.1158/1541-7786.mcr-19-0741↗
- David A. Kooby · 1 shared paper, 2021 · strength 0.15
- Jeffrey A. Drebin · 1 shared paper, 2021 · strength 0.15
- Mihir Maheshkumar Shah · 1 shared paper, 2021 · strength 0.15
- Jashodeep Datta · 1 shared paper, 2021 · strength 0.15
- Jason A. Castellanos · 1 shared paper, 2021 · strength 0.12
- Michael Nathan VanSaun · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.